Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder with typical onset in the 5th -6th decade of life. Selective loss of motor neurons in the primary motor cortex, brainstem and spinal cord result in rapid progressive paralysis of bulbar, limb and voluntary muscles. Although longer survival times exist, death usually occurs within 3 -5 years, mostly because of respiratory failure. The etiology of the disease remains unclear, even though a variety of pathomechanisms such as glutamate excitotoxity, oxidative stress, lack of neurotrophic factors, defects in axonal transport, accumulation of intracellular aggregates and aberrant RNA metabolism have been identified. The earlier hypothesis of an autoimmune origin of ALS receives less attention today, but immunological phenomena still seem to be involved and mechanisms such as protective autoimmunity may be important. Glycolipids, esp. gangliosides are major constituents of the nervous cell membrane, and antibodies against these molecules are found in a variety of neuropathies. Even when symptoms are limited to the lower motor neuron, early ALS is a likely diagnosis, but an important differential diagnosis is multifocal motor neuropathy (MMN). This condition is characterized by high GM1 antibodies of the IgM isotype and can be treated with intravenous immunoglobulins (IVIG). Antibodies against a variety of gangliosides also occur in ALS, but widely differing frequencies and titers have been reported. As part of our effort to identify pathogenic and prognostic factors in ALS, we investigated the presence of IgG and IgM antibodies against 6 gangliosides in a large group of clinically well-characterized ALS patients.
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